Contamination of stomach with h.pylori. Disease of stomach and duodenum, unspecified
Conditions
Interventions
Intervention 1: The study group received 40 mg pantaprazol, 1 g amoxicillin, and 500 mg clarithromycin twice daily plus 30 mL of raw, unfiltered ACV in a glass of water twice daily after meal over 10
Treatment - Other
The study group received 40 mg pantaprazol, 1 g amoxicillin, and 500 mg clarithromycin twice daily plus 30 mL of raw, unfiltered ACV in a glass of water twice daily after meal over 10 days.
The control group received 40 mg pantaprazol, 1 g amoxicillin, and 500 mg clarithromycin twice daily over two weeks.
Sponsors
Ilam University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Positive rapid urease test patients without ulcer; Without consumption of H2 antagonists, proton pump inhibitors and antibiotics in four recent weeks. Without gastrointestinal bleeding in recent four weeks Exclusion criteria: Who can not tolerance apple cider vinegar
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| H.pylori growth. Timepoint: Before treatment. Method of measurement: Rapid Urease Test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Growth of H.Pylori. Timepoint: 4 weeks after completion of treatment. Method of measurement: Breath Urease Test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Vahdat Shariatpanahi
Faculty of Nutrition and Food Sciencees, Shahid Beheshti University of Medical Sciences
Outcome results
None listed